Synthethic path for tuberculosis & chikungunya inhibiting flavonoid molecules

Scientists from Agharkar Research Institute (ARI), Pune, an autonomous institute of the Department of Science and Technology (DST), Govt. of India, have come up with the first synthetic route for producing flavonoids molecules related to the treatment of tuberculosis and chikungunya.

Daily Current Affairs Quiz 2020

Key-Points

Flavonoids are normally isolated from plants. However, inconsistency in natural products can occur in different seasons, places, and species.

Along with these hurdles, over-exploitation of medicinal plants puts an extra burden on the environment.

To overcome these problems, such products can be developed by synthetic protocols in the laboratory by simple and cost-effective methods.

The synthetic natural products possess a structure and medicinal properties similar to the natural product.

The chemical structure of flavonoids is similar to the female hormone 17-beta-estradiol (estrogen). Therefore, flavonoids can ease the life of women who face problems in the premenopausal stage.